UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________

FORM 8-K

______________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 15 , 2016

______________

THE HANOVER INSURANCE GROUP, INC.

(Exact name of registrant as specified in its charter)

 



 

 

 

 

Delaware

 

1-13754

 

04-3263626

(State or other jurisdiction

 

(Commission File Number)

 

(I.R.S.Employer

of incorporation)

 

 

 

Identification No.)



440 Lincoln Street, Worcester, Massachusetts 01653
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (508) 855-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17   CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17   CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17   CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17   CFR 240.13e-4(c))





 


 

Item 5.02 .  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers ; Compensatory Arrangements of Certain Officers .

On May 16, 2016, The Hanover Insurance Group, Inc. (the “ Company ”) announced that, effective June 20, 2016, Joseph M. Zubretsky will assume the role of the Company’s President and Chief Executive Officer and be appointed to the Company’s Board of Directors for a term expiring at the Company’s 2019 annual meeting of shareholders. 

Mr. Zubretsky, 59, joins The Hanover after almost nine years at Aetna, Inc., one of the nation’s largest healthcare benefits and insurance providers, where he most recently served as Chief Executive Officer of Healthagen Holdings, a group of healthcare services and information technology companies.  Prior to that, from 2013 to 2014, he served as Senior Executive Vice President leading Aetna’s National Businesses, a $10 billion business providing health solutions to multi-national companies, and from 2007 to 2013 served as Aetna’s Chief Financial Officer.  Prior to joining Aetna in 2007, Mr. Zubretsky served in a variety of senior management roles in the healthcare and financial services sector.  Mr. Zubretsky began his career as an accountant, rising to partnership in the national insurance industry group at the accounting firm then known as Coopers & Lybrand.  We believe Mr. Zubretsky’s qualifications to serve on our Board include his more than 35 years in the insurance and financial services industry, his management experience leading significant business units at Aetna and elsewhere, his financial experience obtained as the Chief Financial Officer of Aetna and other prominent insurance companies, and as a partner at a major national accounting firm in its national insurance industry group.

As previously announced, effective upon Mr. Zubretsky’s date of hire, Frederick H. Eppinger will retire from his positions as Director, President and Chief Executive Officer.  Until succeeded by Mr. Zubretsky on June 20, 2016, Mr. Eppinger will remain on the Board of Directors as a holdover director .  Thereafter, it is expected that Mr. Eppinger will provide transition assistance to the Company.

In connection with Mr. Zubretsky’s hire, the Company and Mr. Zubretsky entered into an offer letter dated May 15, 2016 (the “ Offer Letter ”), the material terms of which are as follows:



·

Mr. Zubretsky’s annual base salary will be $1,000,000;

·

For 2016, his short-term incentive compensation award (payable in March of 2017) shall equal the lesser of (i) $1,400,000, or (ii) 1% of the Company’s pre-tax operating income, before interest expense on debt and as adjusted to exclude the impact of catastrophes, measured over the six month period ending on December 31, 2016; and for 2017, his target short-term incentive compensation award will be set at 140% of base salary;

·

Mr. Zubretsky’s 2016 long-term equity award will have a grant date fair value of approximately $3,000,000, and will be comprised of the following two separate awards of approximately equal value:

-

Stock Options:  such options will have a ten year term, vest in three approximately equal annual installments commencing on the first anniversary of his date of hire, and have an exercise price equal to the fair market value of the Company’s common stock on his date of hire;

-

Performance-Based Restricted Stock Units (“ PBRSUs ”): the PBRSUs will vest on the third anniversary of his date of hire and may be paid at 0% to 150% of the targeted award based upon the Company’s relative total shareholder return based on a measurement period based on the period from his date of hire through December 31, 2018;

·

Mr. Zubretsky will also receive a sign-on long-term equity award identical to the 2016 long-term equity award;

·

Mr. Zubretsky will participate in the Company’s Amended and Restated Employment Continuity Plan as an “Executive Tier Participant” with a 2X “Multiplier” (without a Section 280G tax gross-up);

·

In the event Mr. Zubretsky’s employment is involuntarily terminated, other than for cause or in connection with a change in control, or he terminates his employment with the Company for “good reason”, he will be eligible to receive severance compensation equal to 2.4 times his base salary with one year’s continued vesting of his then outstanding equity awards;

·

Mr. Zubretsky will be entitled to reimbursement for certain relocation expenses and will be eligible to participate in the Company’s benefit plans applicable to other senior executives of the Company; and

·

Mr. Zubretsky agreed to certain non-solicitation, non-interference and confidentiality provisions in favor of the Company that will survive for at least one year following his termination of employment.



2

 


 

The foregoing description of the terms of the Offer Letter does not purport to be complete and is qualified in its entirety by the Offer Letter attached hereto as Exhibit 10.1, and incorporated herein by reference.



A copy of the press release reporting the announcement of Mr. Zubretsky’s appointment is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 . Financial Statements and Exhibits.

 



 

(d)

Exhibits.

 



 

 



 

 

10.1

  

Offer Letter dated May 15, 2016 by and between Joseph M. Zubretsky and the Registrant.

99.1

 

Press Release of The Hanover Insurance Group, Inc. dated May 16, 2016.



3

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.







 

 



The Hanover Insurance Group, Inc.



(Registrant)



 

 

Date: May 16 , 2016

By:

/s/ J. Kendall Huber

 

J. Kendall Huber

 

Executive Vice President, General

 

Counsel and Asst. Secretary



 



4

 


 

EXHIBIT INDEX







 

 

10.1

  

Offer Letter dated May 15, 2016 by and between Joseph M. Zubretsky and the Registrant.

99.1

 

Press Release of The Hanover Insurance Group, Inc. dated May 16, 2016.



5

 


PICTURE 1

Exhibit 10.1

May   1 5 ,   2016





Joseph M. Zubretsky







Dear Joe :



On behalf of the Board of Directors of The Hanover Insurance Group, Inc. (“The Hanover” or the “Company” ) ,   I am pleased to confirm our offer   for you to join The Hanover as its   President and Chief Executive Officer , reporting to the Board of Directors We believe you are v e ry   well - suited to lead our Company   and we are excited for The Hanover’s   future T he terms of your employment are as follows:



1.

Base Salary:   Effective on the date you commence employment with T he Hanover   (your “ Employment Date”) , your salary will be payable in biweekly installments which annualize to $ 1,000,000



2.

Short-Term Incentive Compensation:    



2016 Short-Term Incentive Compensation Award

You will participate in a   tailored  2 0 1 6   short-term incentive compensation (“STIC”)   program in accordance with the terms of the plan attached hereto as Exhibit A .  



Eligibility for 2017 Short-T erm Compensation Award

Your 2017 STIC target award , for which you will be eligible next year, will equal 140% of your base salary.  Actual payouts, however, may range from 0% to 200% of target depending upon your individual performance and The Hanover’s performance against certain pre-established performance criteria approved by the Compensation Committee and the Committee of Independent Directors (the “CID”) .



Terms and Conditions

The terms and conditions of our annual STIC Programs are establish ed by the Compensation Committee and the CID , typically at the regularly scheduled February meeting s Any STIC payment , including the 2016 award, is contingent upon you being employed at The Hanover at the time the payment is made and is subject to the terms and conditions of the program.



3.

Long-Term Incentive Compensation:  



2016 Long-Term Incentive Compensation Award  

Effective on   your Employment Date, you will be granted a 2016 long-term equity award with a n estimated grant date fair value of approximately $3 ,0 00,000 (the “2016 Award”) Approximately one-h alf of t h e   2016 A ward will be in the form of performance -based restricted

 


 

 

Joseph M. Zubretsky

May 1 5 , 2016

Page 2 of 9

 

 

 

stock units   (“PBRSUs”) that will vest ,   if at all, at a level commensurate with the achievement of the performance metrics applicable to such award ,   o n   the third anniversary of your Employment Date Actual payouts may range from 0% to 150% of the targeted number of units based upon The Hanover’s relative total shareholder return measured from your Employment Date through December 31, 2018.  The balance of this award will be granted in the form of stock options   that will vest in three approximately equal   annual installments commencing on the first anniversary of your Employment Date .

 

Initial Sign-On Long-Term Incentive Compensation Award

E ffective on your Employment Date, y ou will also receive a one-time sign-on long-term equity incentive award with a n estimated grant date fair value of approximately   $ 3,000 ,000 (the Sign- O n Award”) T he Sign- O n Award will be granted in the same form and proportions, and with the same terms and conditions , as the 2016 Award described above .  



Future Long-Term Compensation Awards

You shall be eligible for future annual long-term equity or other grants in such amounts and on such terms and conditions as shall be determined at such times by the Compensation Committee and the CID.



Terms and Conditions

Exhibit B sets forth certain additional terms of these long-term equity awards.  In the case of a conflict between the terms of this Section 3 or Exhibit B , the terms of Exhibit B shall govern.



4.

Relocation :   You will be eligible to receive relocation assistance during the first twenty-four months of your employment under The Hanover Insurance Group Executive Relocation Program.  If you voluntarily terminate your employment without “Good Reason” , or your employment is terminated by The Hanover for “C ause ,   within twenty-four (24) months from the start of your relocation process (the “Measurement Period”) ,   then you will be obligated to repay the unearned portion of such relocation expenses.  The start of the Measurement Period is   the date of the first incurred expense by the relocation vendor.   The “unearned portion of such relocation expenses” shall be calculated by subtracting the number of whole months during the Measurement Period you worked from 24, and dividing the resulting difference by 24, and then multiplying the resulting quotient by the total amount of such relocation expenses.  We will discuss later the terms of your temporary living arrangements, but as a point of clarification, t his “clawback” provision shall not apply to temporary living expenses approved by the Compensation Committee.



5.

Benefits:   You will be eligible to participate in The Hanover ’s benefit programs , including , but not limited to , Group Medical, Dental, Life, Short and Long - Term Disability Insurance, The Hanover Insurance Group Retirement Savings Plan , and our Non-Qualified Retirement Savings Plan .  Eligibility for and entitlements to benefits are determined by the terms and conditions of the applicable benefit plans , as they may be amended from time to time .  



You will be eligible to earn four (4) weeks of vacation annually. 

You will be eligible to participate in the financial planning and matching gifts programs currently available to other senior executives.


 

 

Joseph M. Zubretsky

May 1 5 , 2016

Page 3 of 9

 

 

 



6.

Severance Protection :  



Change   in   Control

You will also be eligible to participate in The Hanover Insurance Group, Inc. Amended and Restated Employment Continuity Plan (the Change in Control Plan ) , in accordance with the terms thereof, as an “ Executive Tier Participant with a 2 X “ Multiplier but without a Section 280G excise tax “gross up” and on a “best net” basis instead .   Participation in the Change in Control Plan requires agreement to certain non-solicitation, non-interference, confidentiality and other covenants as set forth in the plan (a copy of which has been provided to you) , which are applicable whether or not such benefits become available, and no benefits shall be payable unless the Company receives a waiver and releas e and other terms and conditions of the Change in Control Plan are satisfied.



Other Involuntary Termination

In the event your employment is involuntarily terminated, other than for “Cause”   or in conn ection with a Change  i n   Control , or you terminate your employment with the Company for “Good Reason” ,   then you will be eligible to receive severance compensation equal to 2.4 times your base salary payable in a single lump sum cash payment to be paid on a date selected by the Company that is not later than sixty (60) days after your termination of employment; provided ,   however , that if the 60-day period straddles a calendar year, then the payment will be made in the later year during the remainder of the 60-day period .  Additionally, to the extent unvested, you will continue to vest in any long-term equity incentive awards for one (1) year following your termination, but in no event may vesting extend beyond the award’s expiration date in the case of stock option award s.  



As a condition to eligibility for such   severance benefits,   you will be required to execute and return to T he Hanover  a n irrevocable separation agreement in a form that is acceptable to the Company, which shall include a release of claims ,   customary non-solicitation, non-interference, confidentiality, and non-disparagement provisions (but no other covenants that impose restrictions materially more burdensome than those set forth herein) , along with other terms acceptable to the Company .  In the event that the Company believe s th at it has the right to terminate your employment for “Cause,”   the Company must give you written notice of the purported Cause.  The Company shall provide you with notice of such purported Cause w ithin ten ( 10 ) business days after the Board has become aware that Cause has been triggered (except that failure to provide notice timely shall be without prejudice to the Company’s right to terminate you with Cause unless such delay materially impaired your ability to c ure such matter within the time- period hereinafter provided ) If such matter is susceptible to cure, then y ou shall have the right to do so within thirty ( 30 ) days of receipt of said notice.  To the extent that such matter is not susceptible to cure , or you do not cure such event within this thirty (30) day period, the Company shall be required to terminate your employment within thirty (30) days thereafter in order to have your termination of employment treated as a “Cause” termination.     In the event that you believe th at you have the right to terminate your employment for “Good Reason” and receive severance benefits hereunder , you must give the Board of Directors written notice of the purported Good Reason within ten ( 10 ) business days of the first occurrence of such triggering event T he Hanover shall have the right to cure within thirty ( 30 ) days of receipt of said notice.  To the extent that The Hanover does not cure such event within this thirty (30) day period, you


 

 

Joseph M. Zubretsky

May 1 5 , 2016

Page 4 of 9

 

 

 

shall be required to terminate your employment within thirty (30) days thereafter in order to have your termination of employment treated as a “Good Reason” termination.  References in this section to a “termination of employment” shall mean a “separation of service” as defined by Section 409A of the Internal Revenue Code of 1986 ( the “Code ) ( after giving effect to the presumptions contained therein) .  



7.

Covenants and Other Agreements :   The Hanover has certain conditions to employment which apply to all of its officers and senior employees.  A ccordingly, a s a condition of your employment with the Company , you agree that you will (i) not, directly or indirectly, during the term of your employment with The Hanover, and for a period of one year thereafter, hire, solicit, entice away or in any way interfere with The Hanover’s relationship with, any of its officers or employees, or in any way attempt to do so or participate with, assist or encourage a third party to do so ; (ii) at all times, neither disclose any of The Hanover’s confidential or proprietary information to any third party, nor use such information for any purpose other than for the benefit of The Hanover and in accordance with Hanover policy ; (iii) not, during the term of your employment  with The Hanover, and for a period of one year thereafter,  interfere with or seek to interfere with, The Hanover’s relationships with any of its policyholders, custom ers, clients, agents or vendors; and (iv) at all times, comply with The Hanover’s Code of Conduct and other policies and procedures as in effect from time to time.   For the purposes of this provision, “confidential” or “proprietary” information shall include any information concerning the business, prospects, and goodwill of The Hanover including, by way of illustration and not limitation, all information (whether or not patentable or copyrightable) owned, possessed or used by The Hanover including , without limitation , any agent or vendor information, client information, potential agent or client lists, trade secrets, reports, technical data, computer programs, software documentation, software development, marketing or business plans, unpublished financial information, budgeting/price/cost information or agent, broker, employee or insured’s lists or compensation information, except to the extent such information is otherwise legally and publicly available .



8.

Representations and Other Considerations Please be advised that to the extent you are subject to any employment or contractual obligations to prior employer(s), the Company expects you to comply with such obligations and to inform the Company accordingly. The Hanover respects its competitors’ trade secrets and confidential information.  Please do not bring with you any confidential information or proprietary information from any of your prior employers, and please do not use such information at any time, in any way, during the course of your employment with The Hanover.



You represent that you have provided The Hanover with copies of any agreement or employment polic ies , including any code of conduct or similar policies , that may set forth any continuing obligations to such prior employer(s), and that you are not aware of any agreement or employment policy of any kind that will prevent you from fulfilling , or that in any way could interfer e or adversely affect   you r ability to ful fill , your responsibilities to The Hanover in the capacities contemplated .   You represent that you have no reason to believe that any regulatory authority in the U.S., United Kingdom, European Union, or elsewhere , including , but not limited to   the U.S. Securities and Exchange Commission, various state departments of insurance, the U.K. Financial Conduct Authority and the U.K. Prudential Regulatory Authority, would object to you becoming an officer and director of T he Hanover or of any of its insurance and non-


 

 

Joseph M. Zubretsky

May 1 5 , 2016

Page 5 of 9

 

 

 

insurance subsidiaries.  You also represent that you are not aware of any other impediment to your ability to fulfill the responsibilities contemplated as President, Chief Executive Officer and a Director of T he Hanover or any of its subsidiaries.



9.

Miscellaneous:



Electronic Payment : As a condition of employment, all employees are paid through Electronic Funds Transfer (EFT). 



Employment Eligibility :   Under the Federal immigration law, you will be required to complete an I-9 form verifying your employment eligibility in the United States on or prior to your Employment Date .  We will provide you with a list of acceptable forms of documentation. 



At-Will Employment Relationship :   This offer letter briefly summarizes some of the terms and conditions of your employment.  This letter is not and should not be construed as an employment contract.  Employment at T he Hanover is at-will.  This means that you or the Company can terminate the employment relationship at any time, for any reason or no reason at all, with or without cause or notice.



Other Activities :  You may, with the permission of the Board, accept outside directorships (but no more than one public company) and engage in other activities for civic and charitable organizations to the extent doing so does not interfere or adversely affect your ability to ful fill your responsibilities to The Hanover in the capacities contemplated. 



Definitions :  Certain terms used herein or in the Exhibits hereto have the meanings assigned to them in Exhibit C .



Entire Agreement; Governing Law :   This letter agreement sets forth the entire agreement between you and the Company and replaces all prior and contemporaneous communications, agreement s and understandings, written or oral, with respect to the terms and conditions of your employment .  This letter agreement and your employment relationship shall be governed by the laws of Massachusetts, without regard to the law of conflicts.



Company Policies:  You shall be subject to the Company’s policies as in effect from time to time, including stock ownership guidelines applicable to executive officers, Insider Trading Policy, Policy Regarding Recoupment of Formulae-Based Performance Compensation , and policies relating to hedging and pledging of securities linked to T he H anover.  



Withholding :  All payments made by the Company under this agreement shall be reduced by any tax or other amounts required to be withheld by the Company under applicable law.



10.

Other:  Our current plan is to announce your appointment on Monday, May 16, 2016 , effective June 20 ,   2016 ,   which would be your actual E mployment D ate. We will elect you as a   non-independent director of  T he H anover   effective on your Employment Date.   No additional compensation is payable to management member s for Board service .




 

 

Joseph M. Zubretsky

May 1 5 , 2016

Page 6 of 9

 

 

 

Joe, we are truly excited about y ou r decision to join The Hanover .   The entire B oard look s forward to working with you.  





Very truly yours ,





/s/ Michael Angelini

Michael Angelini

Chairman of the Board

The Hanover Insurance Group, Inc.







/s/ P. Kevin Condron                                                                            

P. Kevin Condron

Chairman of the Search Committee

and of the Compensation Committee

The Hanove r Insurance Group, Inc.



Accepted and Agreed:





/s/ Joseph M. Zubretsky

Name: Joseph M. Zubretsky

Date: May 15, 2016


 

 

Joseph M. Zubretsky

May 1 5 , 2016

Page 7 of 9

 

 

 

Exhibit A



2016 Annual Short-Term

Incentive Compensation Plan



The award payable under this program will equal the lesser of (i) 1 % of T he Hanover ’s pre-tax operating income, before interest expense on debt and as adjusted to exclude the impact of catastrophes, measured over the six month period ending on December 31, 2016, as reported on the Company’s financial statements as filed with the Securities and Exchange Commission on a Form 8-K (including as a cover to the year-end earnings press release ) or Form 10-K and certified by the Company’s Chief Financial Officer ;   or (ii) 140% of your 2016 annualized base salary . Such award will be issued pursuant to, and subject to the terms of, the 2014 Executive Short-Term Incentive Compensati o n Plan, will be payable in March 2017 at such time as 2016 STI C awards are payable to other executives of the Company, and shall be subject to such further terms and conditions as are designed to ensure its compliance with Section 162(m) of the Code and to such administrative rules and conditions as otherwise apply to the Company’s Executive and Leadership STIC Plan s




 

 

Joseph M. Zubretsky

May 1 5 , 2016

Page 8 of 9

 

 

 

Exhibit B



Certain Additional Terms Applicable to Long-Term Equity Awards



Retirement You r 2016 Award, Sign-O n Award and any future long-term equity awards will provide for pro-rated vesting of PBRSUs upon R etirement .     Additionally, upon R etirement, any then vested stock options shall remain exercisable for a period of three (3) years (but in no event later than the option’s scheduled expiration date and subject to earlier cancellation as provided under Award Terms below) .    



Award Terms : Except as otherwise provided herein, all s uch awards shall be subject to the terms and conditions of The Hanover Insurance Group 2014 Long-Term Incentive Plan (the “2014 Plan”) or any successor long-term equity plan of the Company   and the standard   Company grant agreements as in effect from time to time (the “Grant Agreements”) .  For purposes of determining the Company’s relative total shareholder return with respect to the 2016 and Sign-on Award PBRSUs, the Company will adopt the same methods and methodologies, to the extent practicable, as apply to the 2016 grants of PBRSUs made to other executive officers of the Company.     Notwithstanding any provision of any stock option awards which provide for an extended exercise period following separation from the Company, in the event of a Change in Control (as defined in the 2014 Plan) or other extraordinary transaction pursuant to which options are cashed-out, converted to or exchanged for another right, cancelled, or otherwise amended, such awards   shall be subject to the same treatment, which may include cancellation, as shall apply generally to all executive-level holders of   vested stock options .  For example, in the event the terms of any such transaction provide for the cancellation of options which are “out - of - the - money”   at the designated time, any out-of-the-money vested options then held by you shall similarly be subject to cancellation and the extended right to exercise such options shall not survive.



Change   in   Control In the event of a Change in C ontrol (as defined in the 2014 Plan) , any vested or unvested equity awards will be subject to the same terms , conditions and rights as are set forth in all other awards governed by Grant Agreements except that, notwithstanding any other provision to the contrary, including any rights otherwise triggered by the subsequent involuntary termination of your employment by the Company (or its successor) or constructive termination by you, no equity-based awards granted pursuant to this letter agreement or otherwise within twelve months from your Employment Date, shall be subject to accelerated vest ing   (or conversion) as a result of such events without the explicit approval of the CID in its sole discretion .  For avoidance of doubt and in the event of a Change in Control, and unless otherwise agreed, any such awards granted after the one-year anniversary of the Employment Date shall be governed by the terms of the standard plan agreements in effect from time to time.



 






 

 

Joseph M. Zubretsky

May 1 5 , 2016

Page 9 of 9

 

 

 

Exhibit C



Selected Definitions





Except as provided herein, capitalized terms used herein without definition shall have the following meanings:    



The term “Cause” shall mean:  (i) your continued willful failure to perform substantially your duties with the Company or any affiliate (other than any such failure resulting from your incapacity due to disability within the meaning of the Company's short-term disability plan as in effect at the time such determination is made) after ten (10) days prior written notice from the Board; (ii) your conviction of, or plea of guilty or nolo contendere to, a misdemeanor involving theft or embezzlement, or a felony; (iii) your willful engagement in illegal conduct or gross misconduct which is demonstrably and materially injurious to the Company or any affiliate; (iv) your material breach of any non - disclosure or non - solicitation agreement with the Company or any affiliate; (v) your willful violation of a posted Company policy applicable to all employees which violation is demonstrably and materially injurious to the Company or any affiliate; or (vi) any material breach of your representations, covenants and other obligations and agreements set forth in this letter agreement.  “Cause” may not be alleged except upon a determination by the Board of Directors of the Company.    



The term “Good Reason” shall mean (i) any material and adverse change with respect to your authority, duties or responsibilities; (ii) a reduction in your rate of annual base salary as set forth in the letter agreement; (iii) a reduction in your annual short-term incentive compensation plan target award (but excluding the conversion of any cash incentive arrangement into an equity incentive arrangement of commensurate value or vice versa) from that set forth in the letter agreement; (iv) a material reduction in health, welfare and retirement benefits offered as of the date of this letter agreement, unless the reduction applies similarly to all domestic executive officers of the Company; (v) any requirement that you relocate to an office more than 35 miles from the Worcester facility; (vi) any failure of the Board to nominate you to the Board of Directors at the end of your then current term; or (vii) your removal as a director by action of the Board of Directors; in each case set forth in clauses (vi) and (vii), without Cause.  Notwithstanding the foregoing with respect to subsections (ii) and (iii) above, reductions to your annual base salary and/or target annual short-term incentive compensation of less than 10% in the aggregate, taking into account any prior reductions to the same, shall not be deemed “Good Reason” if such reductions are applied to all senior executives at the Company or the applicable successor entity, as applicable .  



The term “Change in Control” shall have the meaning in the Change in Control Plan.



The term “Retirement” as used in Exhibit B only, shall mean your termination of employment with the Company for any reason other than by the Company for “Cause”,  following your attainment of age 65.



The terms “the Company” and “The Hanover” shall include, depending on the context, the direct and indirect subsidiaries of The Hanover Insurance Group, Inc.








PICTURE 11











The Hanover Insurance Group Names Joseph M. Zubretsky

President and Chief Executive Officer



WORCESTER, Mass., May 16 , 2016 — The Hanover Insurance Group , Inc. (NYSE: THG) today announced that it has named Joseph M. Zubretsky president, chief executive officer, and director effective June 20 .   He succeeds Frederick H. Eppinger, who last fall announced his intention to retire. They will work closely in the coming weeks to manage a smooth transition in leadership.





J_ZUBRETSKY_FINAL

PICTURE 17

Zubretsky , 59,   is an accomplished leader with more than 35 years of experience in the insurance and financial services industries. He joins The Hanover after almost nine years at Aetna , a Fortune 50 insurer, where he served most recently as chief executive officer   at Healthagen Holdings , a group of healthcare services and information technology companies , and a member of Aetna’s executive committee. Prior to that , he was senior executive vice president leading National Businesses, a $10 billion Aetna flagship business that provides health solutions to multi-national companies, and Aetna’s executive vice president and chief financial officer.

      

“We are thrilled to welcome Joe to The Hanover,” said Michael P. Angelini, chairman of The Hanover’s board of directors. “He brings broad insurance experience, a deep understanding of the independent agency distribution channel, a strategic orientation, risk management expertise, and an impressive record of building market-leading companies . Our board is confident that he is uniquely qualified to work with our exceptional leadership team to continue our company’s success and expand our business . We have every expectation that Joe and our team will take our company to the next level .




 

“I am excited to have the opportunity to join this great company ,” said Zubretsky. “I have tremendous respect for the organization , its values and its talented employees .     I   look forward to working with the outstanding team at The Hanover, to build on the company’s excellent market position , deliver high-quality insurance solutions, strong and sustainable profitable growth, and superior value for our shareholders and all of our other stakeholders.”



Commenting on outgoing CEO Fred Eppinger, Angelini said, To call Fred’s service to The Hanover exceptional is to understate it. He inherited a smaller, regional company and led its transformation over 13 years into a respected, leading national carrier with international capabilities , inspiring many and creating tremendous shareholder value. This is a success story of the highest order. ”  



“I am very proud of all that our talented and dedicated team has achieved, creating an organization that is recognized as one of the best in our industry,” Eppinger said. “ W ith our company stronger and better positioned than ever, Joe brings experience and a perspective that will enable the organization to reach its full potential and pros per over the long term, benefit ing its many constituents.”  



Zubretsky   joined Aetna from Unum Group, where he was senior executive vice president, responsible for the company’s finance, investments, marketing, strategy and risk operations, from 2005 to 2007. Previously, he was a partner at the global private equity firm of Brera Capital Partners and executive vice president of business development and chief financial officer at MassMutual Financial Group. He began his career as an accountant at Coopers & Lybrand, becoming partner of its National Insurance Industry Group.





ABOUT THE HANOVER



The Hanover Insurance Group, Inc., based in Worcester, Mass., is the holding company for several property and casualty insurance companies, which together constitute one of the largest insurance businesses in the United States. For more than 160 years, The Hanover has provided a wide range of property and casualty products and services to individuals, families, and businesses. The Hanover distributes its products through a select group of independent agents and brokers. Together with its agents, the company offers specialized coverages for small and mid-sized businesses, as well as insurance protection for homes, automobiles, and other personal items. Through its international member company, Chaucer, The Hanover also underwrites business at Lloyd's of London in several major insurance and reinsurance classes, including marine, property and energy. For more information, please visit   hanover.com .




 

CONTACT INFORMATION:

Investors:

Oksana Lukasheva

Email: olukasheva@hanover.com    

508-855-2063

Media:

Michael F. Buckley

Email: mibuckley@hanover.com

508-855-3099



Emily P. Trevallion

Email: etrevallion@hanover.com

508-855-3263  







IMAGE